T2 Biosystems, Inc. (TTOO)
Company Info
| ISIN | US89853L1044 |
|---|---|
| CUSIP | 89853L104 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| IPO Date | Aug 7, 2014 |
Highlights
| Market Cap | $9.16M |
|---|---|
| EPS (TTM) | $29.70 |
| PE Ratio | 0.02 |
| Total Revenue (TTM) | $5.69M |
| Gross Profit (TTM) | -$3.78M |
| EBITDA (TTM) | -$22.18M |
| Year Range | $0.51 - $8.38 |
| Target Price | $5.00 |
| Short % | 5.01% |
| Short Ratio | 1.26 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: TTOO vs. VGR, TTOO vs. VTSAX, TTOO vs. TQQQ, TTOO vs. TCEHY, TTOO vs. SCHD, TTOO vs. AMGN, TTOO vs. PFE
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in T2 Biosystems, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
T2 Biosystems, Inc. had a return of -91.27% year-to-date (YTD) and -87.71% in the last 12 months. Over the past 10 years, T2 Biosystems, Inc. had an annualized return of -69.61%, while the S&P 500 had an annualized return of 11.39%, indicating that T2 Biosystems, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -91.27% | 25.48% |
| 1 month | -62.72% | 2.14% |
| 6 months | -90.82% | 12.76% |
| 1 year | -87.71% | 33.14% |
| 5 years (annualized) | -85.67% | 13.96% |
| 10 years (annualized) | -69.61% | 11.39% |
Monthly Returns
The table below presents the monthly returns of TTOO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -28.29% | 12.00% | -40.48% | 11.83% | 53.20% | 3.89% | -8.61% | -34.63% | -38.24% | -55.54% | -91.27% | ||
| 2023 | 10.56% | -60.83% | -25.20% | -28.26% | -72.73% | -21.56% | 108.92% | 112.20% | -29.42% | -73.25% | -40.10% | 77.26% | -95.58% |
| 2022 | -18.64% | 3.60% | 20.46% | -29.40% | -45.30% | -20.21% | -25.33% | 1.58% | -7.76% | -67.26% | -10.27% | -14.46% | -94.50% |
| 2021 | 60.48% | 15.08% | -29.26% | -14.81% | 0.72% | -14.39% | -13.45% | -9.27% | -2.07% | -15.37% | -19.97% | -16.72% | -58.37% |
| 2020 | -23.92% | -22.55% | -5.79% | -16.04% | 53.92% | 51.32% | 30.71% | -6.02% | -12.82% | -1.47% | -17.16% | 11.71% | 5.98% |
| 2019 | 16.28% | 24.00% | -39.40% | -2.28% | -24.12% | -13.85% | -64.88% | 125.42% | 87.97% | -2.00% | -44.49% | -13.97% | -61.13% |
| 2018 | 20.15% | 6.06% | 23.62% | -1.08% | 15.42% | 4.45% | -22.61% | 9.02% | 14.09% | -29.53% | -15.43% | -32.21% | -26.94% |
| 2017 | 2.66% | 4.63% | -6.90% | -8.56% | -31.19% | -3.02% | -18.07% | 59.32% | 0.24% | -11.19% | 12.06% | -1.44% | -21.67% |
| 2016 | -18.92% | -9.92% | 23.40% | -7.00% | -6.00% | -8.47% | -28.26% | 17.31% | 9.04% | -12.71% | -7.75% | -9.78% | -51.92% |
| 2015 | 12.42% | -23.35% | -6.39% | -0.32% | 8.53% | -3.34% | -11.21% | -17.56% | -26.26% | 26.94% | 6.03% | -7.21% | -43.14% |
| 2014 | 62.08% | -22.06% | -10.72% | 10.96% | 7.37% | 34.36% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of TTOO is 5, indicating that it is in the bottom 5% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for T2 Biosystems, Inc. (TTOO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the T2 Biosystems, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the T2 Biosystems, Inc. was 100.00%, occurring on Nov 12, 2024. The portfolio has not yet recovered.
The current T2 Biosystems, Inc. drawdown is 100.00%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Jan 15, 2015 | 2474 | Nov 12, 2024 | — | — | — |
| -40.24% | Sep 2, 2014 | 37 | Oct 22, 2014 | 57 | Jan 14, 2015 | 94 |
| -11.06% | Aug 21, 2014 | 1 | Aug 21, 2014 | 6 | Aug 29, 2014 | 7 |
| -6.42% | Aug 8, 2014 | 1 | Aug 8, 2014 | 2 | Aug 12, 2014 | 3 |
| -1.68% | Aug 15, 2014 | 1 | Aug 15, 2014 | 1 | Aug 18, 2014 | 2 |
Volatility
Volatility Chart
The current T2 Biosystems, Inc. volatility is 34.98%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of T2 Biosystems, Inc. compared to its peers in the Diagnostics & Research industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for TTOO in comparison to other companies of the Diagnostics & Research industry. Currently, TTOO has a PE value of 0.0. This PE value is considered to be low compared to the rest of the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for TTOO in comparison to other companies of the Diagnostics & Research industry. Currently, TTOO has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for T2 Biosystems, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |